A citation-based method for searching scientific literature

C Liguori, L Ferini-Strambi, F Izzi, L Mari, N Manfredi, A D'Elia, N B Mercuri, F Placidi. Br J Clin Pharmacol 2019
Times Cited: 9







List of co-cited articles
73 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Effects of Antidepressants on Sleep.
Adam Wichniak, Aleksandra Wierzbicka, Małgorzata Walęcka, Wojciech Jernajczyk. Curr Psychiatry Rep 2017
106
55

Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder.
A Mørk, A Pehrson, L T Brennum, S Møller Nielsen, H Zhong, A B Lassen, S Miller, L Westrich, N J Boyle, C Sánchez,[...]. J Pharmacol Exp Ther 2012
188
44

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions.
Grace Chen, Astrid-Maria Højer, Johan Areberg, George Nomikos. Clin Pharmacokinet 2018
29
44

Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
Benny Bang-Andersen, Thomas Ruhland, Morten Jørgensen, Garrick Smith, Kristen Frederiksen, Klaus Gjervig Jensen, Huailing Zhong, Søren Møller Nielsen, Sandra Hogg, Arne Mørk,[...]. J Med Chem 2011
253
33

Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes/macrophages.
Maria Talmon, Silvia Rossi, Anna Pastore, Carlo Ignazio Cattaneo, Sandra Brunelleschi, Luigia Grazia Fresu. Br J Pharmacol 2018
19
33

Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research.
Djamila Bennabi, Emmanuel Haffen, Vincent Van Waes. Front Psychiatry 2019
12
33


Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins,[...]. Lancet 2018
824
33


Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial.
Bing Cao, Caroline Park, Joshua D Rosenblat, Yan Chen, Michelle Iacobucci, Mehala Subramaniapillai, Rodrigo B Mansur, Hannah Zuckerman, Yena Lee, Roger S McIntyre. J Psychopharmacol 2019
7
42


The effect of vortioxetine on overall patient functioning in patients with major depressive disorder.
Ioana Florea, Henrik Loft, Natalya Danchenko, Benoît Rive, Melanie Brignone, Elizabeth Merikle, Paula L Jacobsen, David V Sheehan. Brain Behav 2017
11
22


Sleep and psychiatry.
Vivien C Abad, Christian Guilleminault. Dialogues Clin Neurosci 2005
45
22



Sleep as a biomarker for depression.
Adam Wichniak, Aleksandra Wierzbicka, Wojciech Jernajczyk. Int Rev Psychiatry 2013
43
22

Sleep Disturbances in Mood Disorders.
Meredith E Rumble, Kaitlin Hanley White, Ruth M Benca. Psychiatr Clin North Am 2015
57
22


Vortioxetine (brintellix): a new serotonergic antidepressant.
Andrew D'Agostino, Clayton D English, Jose A Rey. P T 2015
28
22

A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms.
David S Baldwin, Ioana Florea, Paula L Jacobsen, Wei Zhong, George G Nomikos. J Affect Disord 2016
28
22

A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults.
Michael E Thase, Atul R Mahableshwarkar, Marianne Dragheim, Henrik Loft, Eduard Vieta. Eur Neuropsychopharmacol 2016
59
22

Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder.
Michael R Liebowitz, Jason Careri, Kyra Blatt, Ann Draine, Junko Morita, Melissa Moran, Rita Hanover. Depress Anxiety 2017
13
22

SSRI Antidepressant Medications: Adverse Effects and Tolerability.
James M. Ferguson. Prim Care Companion J Clin Psychiatry 2001
321
22

Population pharmacokinetic meta-analysis of vortioxetine in healthy individuals.
Johan Areberg, Kamilla B Petersen, Grace Chen, Himanshu Naik. Basic Clin Pharmacol Toxicol 2014
25
22

Altering metabolic profiles of drugs by precision deuteration: reducing mechanism-based inhibition of CYP2D6 by paroxetine.
Vinita Uttamsingh, Richard Gallegos, Julie F Liu, Scott L Harbeson, Gary W Bridson, Changfu Cheng, David S Wells, Philip B Graham, Robert Zelle, Roger Tung. J Pharmacol Exp Ther 2015
21
22



Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.
J E J Buckman, A Underwood, K Clarke, R Saunders, S D Hollon, P Fearon, S Pilling. Clin Psychol Rev 2018
75
22

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.
Søren H Sindrup, Lars F Gram, Kim Brøsen, Ole Eshøj, Erik F Mogensen. Pain 1990
328
22


Antidepressants of different classes cause distinct behavioral and brain pro- and anti-inflammatory changes in mice submitted to an inflammatory model of depression.
Viviane de Sousa Tomaz, Adriano José Maia Chaves Filho, Rafaela Carneiro Cordeiro, Paloma Marinho Jucá, Michelle Verde Ramo Soares, Poliana Noronha Barroso, Larissa Maria Frota Cristino, Wei Jiang, Antônio Lúcio Teixeira, David F de Lucena,[...]. J Affect Disord 2020
20
22

A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder.
Paula L Jacobsen, Atul R Mahableshwarkar, Michael Serenko, Serena Chan, Madhukar H Trivedi. J Clin Psychiatry 2015
64
22

A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder.
Atul R Mahableshwarkar, Paula L Jacobsen, Michael Serenko, Yinzhong Chen, Madhukar H Trivedi. J Clin Psychiatry 2015
55
22

Enhanced long-term synaptic depression in an animal model of depression.
Roman Holderbach, Kristin Clark, Jean-Luc Moreau, Josef Bischofberger, Claus Normann. Biol Psychiatry 2007
137
22

Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain.
Anna Rita Zuena, Daniela Maftei, Giovanni Sebastiano Alemà, Francesca Dal Moro, Roberta Lattanzi, Paola Casolini, Ferdinando Nicoletti. Mol Pain 2018
11
22

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.
N Attal, G Cruccu, R Baron, M Haanpää, P Hansson, T S Jensen, T Nurmikko. Eur J Neurol 2010
22

Off-label Antidepressant Use for Treatment and Management of Chronic Pain: Evolving Understanding and Comprehensive Review.
Ivan Urits, Jacquelin Peck, Mariam Salisu Orhurhu, John Wolf, Riki Patel, Vwaire Orhurhu, Alan D Kaye, Omar Viswanath. Curr Pain Headache Rep 2019
23
22

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Nanna B Finnerup, Nadine Attal, Simon Haroutounian, Ewan McNicol, Ralf Baron, Robert H Dworkin, Ian Gilron, Maija Haanpää, Per Hansson, Troels S Jensen,[...]. Lancet Neurol 2015
22


Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant.
Magdalena Sowa-Kućma, Patrycja Pańczyszyn-Trzewik, Paulina Misztak, Rafał R Jaeschke, Katherine Sendek, Krzysztof Styczeń, Wojciech Datka, Magdalena Koperny. Pharmacol Rep 2017
30
22

Duloxetine vs. placebo in patients with painful diabetic neuropathy.
David J Goldstein, Yili Lu, Michael J Detke, Thomas C Lee, Smriti Iyengar. Pain 2005
509
22


Vortioxetine: a novel antidepressant for the treatment of major depressive disorder.
Xenia Gonda, Samata R Sharma, Frank I Tarazi. Expert Opin Drug Discov 2019
21
22

The Involvement of Descending Pain Inhibitory System in Electroacupuncture-Induced Analgesia.
Qiuyi Lv, Fengzhi Wu, Xiulun Gan, Xueqin Yang, Ling Zhou, Jie Chen, Yinjia He, Rong Zhang, Bixiu Zhu, Lanying Liu. Front Integr Neurosci 2019
16
22

The association between burning mouth syndrome and sleep disturbance: A case-control multicentre study.
D Adamo, A Sardella, E Varoni, C Lajolo, M Biasotto, G Ottaviani, P Vescovi, T Simonazzi, M Pentenero, M Ardore,[...]. Oral Dis 2018
24
22


Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study.
Daniela Adamo, Giuseppe Pecoraro, Massimo Aria, Gianfranco Favia, Michele Davide Mignogna. Pain Med 2020
9
22

Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.
Roger S McIntyre, Ioana Florea, Brigitte Tonnoir, Henrik Loft, Raymond W Lam, Michael Cronquist Christensen. J Clin Psychiatry 2017
45
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.